Lyell Immunopharma News

Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(3.93%)

Nov 13 05:12

Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(3.93%)

Nov 5 02:34

Lyell Immunopharma | 3: Initial statement of beneficial ownership of securities-Director Ramachandra Sumant

Nov 2 04:58

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Ramachandra Sumant

Nov 2 04:57

Lyell Immunopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-James Tananbaum (“Tananbaum”)(5.3%),Foresite Capital Fund IV, L.P. (“FCF IV”)(3.2%), etc.

Nov 1 06:00

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NELSEN ROBERT

Jun 18 04:45

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Klausner Richard

Jun 18 04:24

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Bishop Hans Edgar

Jun 18 04:23

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director RIEFLIN WILLIAM JL

Jun 18 04:19

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NABEL ELIZABETH G

Jun 18 04:13

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director BRAWLEY OTIS W

Jun 18 04:11

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director FRIEDMAN CATHY

Jun 18 04:11

Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%), etc.

Feb 15 04:24

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lang Matthew

Feb 14 09:31

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Hill Stephen J.

Feb 14 09:26

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lee Gary K.

Feb 14 09:26

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Newton Charles W.

Feb 14 09:21

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Seely Lynn

Feb 14 09:21

Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.40%)

Feb 14 06:52

Lyell Immunopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.7%)

Jan 30 06:37